CIK 0001453687 · Non-accelerated filer<br>Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- 4 Grant or award Chief Operations Officer acquired 16,100 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 22,000 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 19,000 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 16,100 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Grant or award Director acquired 2,600 shares (grant or award)
- 4 Gift Director gave 20,000 shares (gift)
- 4 Option exercise SVP, Head of Manufacturing acquired 7,650 shares (option exercise)
- 4 Open-market buy Director bought 52,189 shares at an average $18.49 ($965,021)
- 4 Open-market sale Chief Technology Officer sold 13,664 shares at an average $25.26 ($345,134)
- 4 Open-market sale Chief Technology Officer sold 38,689 shares at an average $16.78 ($649,030)
- 4 Gift Director gave 28,821 shares (gift)
- 4 Option exercise Chief Scientific Officer acquired 14,000 shares (option exercise)
- 4 Open-market buy Director bought 431,940 shares at an average $17.07 ($7,373,527)
Page 3 of 21 · 410 filings